Literature DB >> 34234447

Lumbar Extradural Pseudogout Mass Manifesting as Radiculopathy: A Case Report.

Po-Cheng Lo1, Chung-Tai Yue2, Woon-Man Kung3.   

Abstract

BACKGROUND: Calcium pyrophosphate dihydrate (CPPD) disease, also known as pyrophosphate arthropathy or pseudogout, is defined as CPPD deposition within the articular cartilage. It was first described in 1962. The representative locations where CPPD disease occurs include the most common knee joint, followed by the wrist joint. Joint swelling and pain are the most common clinical presentations, and the typical differential diagnosis is degenerative arthritis. Microscopically, the specimen demonstrates numerous positively birefringent rhomboid shaped crystals when examined under polarized light. CASE REPORT: We present a 70-year-old female with right painful sciatica accompanied by coexisting affected limb soreness and clumsiness. Her final diagnosis was unusual lumbar extradural tumoral pseudogout that was worth noticing. Tumoral CPPD deposition was excised after laminectomy. Subsequently, her symptoms were abated postoperatively without a need for more analgesics. Her neurological function was properly recovered.
CONCLUSION: This is a rare report to proffer pseudogout in an unfamiliar lumbar extradural location, which is an unexpected diagnosis. Making a precise tentative diagnosis for the ongoing disease entity might be difficult for the clinicians because the clinical manifestations of this pathology are similar to those of other common degenerative lumbar spinal diseases.
© 2021 Lo et al.

Entities:  

Keywords:  birefringent crystals; calcium pyrophosphate dihydrate; lumbar extradural tumor; polarized light microscopy; sciatica

Year:  2021        PMID: 34234447      PMCID: PMC8253935          DOI: 10.2147/JMDH.S316738

Source DB:  PubMed          Journal:  J Multidiscip Healthc        ISSN: 1178-2390


Background

Calcium pyrophosphate dihydrate (CPPD) deposition typically refers to an inflammatory arthropathy of the peripheral joints, better known as pseudogout. Nevertheless, neurological symptoms caused by the accumulation of these crystals inside the spinal canal are relatively uncommon.1 In 2011, the European League Against Rheumatism (EULAR) proposed a standardized terminology to the clinical presentation that acute CPPD crystal arthritis is synovitis in the setting of CPPD.2 Acute CPP crystal arthritis (or pseudogout) is the most widely known form of CPPD. Patients usually present with acute attacks of single-joint or oligo-joint arthritis. The knee joint is the most commonly affected joint, followed by the wrist joint. Systemic symptoms include fever, chills, and general malaise, which often occur with acute CPP crystal arthritis. Most patients with chronic CPPD arthritis have a polyarticular form of arthritis similar to degenerative arthritis. A small number of patients will show signs of polyarthritis similar to rheumatoid arthritis but less symmetry.3 Crystalline synovial fluid analysis is a simple procedure. With proper training, it is best to use freshly aspirated synovial fluid for examination within 24 hours to make a clear diagnosis of gout and CPPD arthritis.4,5 Twelve cases of pseudogout within the lumbar spinal canal have been presented in patients from 1991 to 2021 (Table 1). We report our unique case that was initially misdiagnosed as acute right sciatica, and eventually diagnosed as a pseudogout outgrowth located in the lumbar vertebral canal. Although rare, clinicians should be aware of neurological symptoms such as radiculopathy as a result of CPPD deposition compromising the neural elements as a possible differential diagnosis.
Table 1

Summary of Reported Cases of Lumbar Intraspinal CPPD

Author(s)YearAge/GenderRadiological LocationClinical Features/ DurationPeripheral Joint InvolvementTreatmentCase NumberTotal Number
Brown et al231991Mean 66.2/ unknownL3-4 (2), L4-5 (1) ligamentum flavumLBP (2), left sciatica (1)/ unknownUnknownLaminectomy33
Salcman et al24199450/FLeft L4-5 disc spaceLBP, left sciatica/ unknownUnknownHemi-laminotomy14
Baty et al25200339/FL1-2 disc spaceLBP/ 1 monthAbsentDecompression and fusion15
Lam et al26200779/F72/FL3-4 ligamentum flavum, L4-5 epidural spaceLBP, both limbs numbness/ 2 weeks bilateral limbs numbness/ 1 yearUnknownLaminectomy27
Mikhael et al27201360/ML5-S1 disc spaceLBP, bilateral sciatica/ 2 monthsAbsentDecompression and fusion18
Cacciotti et al28, †201350/FL3-L4 intradural spaceBoth legs progressive weakness and claudication/ 14 yearsPresentLaminectomy19
Grobost et al29201485/ML4-5 epidural spaceLBP/ 4 yearsPresentColchicine therapy110
Greca et al30202080/FL4-5 ventral epidural spaceLBP, left buttock and leg numbness/ 6 monthsPresentImage-guided biopsy and aspiration111
Chakravorty et al31, †202181/ML1 intradural extramedullaryLBP, both feet numbness/ 40 yearsUnknownLaminectomy112

Notes: †Cases of intradural CPPD.

Abbreviations: M, male; F, female; LBP, low back pain.

Summary of Reported Cases of Lumbar Intraspinal CPPD Notes: †Cases of intradural CPPD. Abbreviations: M, male; F, female; LBP, low back pain.

Case Report

A 70-year-old female visited our neurosurgical outpatient clinic with a two-year history of right painful sciatica at the dorsal aspect of the right foot with coexisting affected limb soreness and clumsiness, which was compatible with a right L5 dermatome, and worsened over the last two months, necessitating the prescription of nonsteroidal anti-inflammatory drugs (NSAIDs). Her neurological presentation further aggravated to become an intractable right buttock pain accompanied with lower limb weakness, and she was even referred to the emergency department because of an inevitable injury due to an accidental fall that occurred as a consequence of her unsteady gait. Careful assessments revealed a positive straight leg raising test on the right at 70 degree; however, this test was negative on the left. On laboratory examination, patient’s complete blood count, C-reactive protein, and urinalysis were normal. Biochemistry reports including uric acid (4.1 mg/dL) and electrolytes were all within normal ranges. Plain radiographs showed neither bony fracture over her right hip nor the pathognomonic chondrocalcinosis of the lumbar spine. Axial-sagittal magnetic resonance imaging (MRI) revealed extradural cystic tumors causing moderate indentation and displacement of the L4-5 thecal sac and cauda equina, together with an extension into the corresponding right neuroforamen (Figure 1A and B). The lesion showed in the MRI was low intensity on T1 weighted and high intensity on T2 weighted, which implied a fluidic content. Further gadolinium enhanced survey revealed a weak rim enhancement of the structure.
Figure 1

T2 weighted magnetic resonance imaging of the lumbar spine: coupled extradural cystic high intensity tumors on sagittal view (A) and axial view (B). Arrows demonstrating displacement of the L4-5 thecal sac and cauda equina with an extension into the corresponding right neuroforamen. Intraoperative photograph (C) showing the extradural tumor (black arrow) located at the right side of the dural sac (white arrow).

T2 weighted magnetic resonance imaging of the lumbar spine: coupled extradural cystic high intensity tumors on sagittal view (A) and axial view (B). Arrows demonstrating displacement of the L4-5 thecal sac and cauda equina with an extension into the corresponding right neuroforamen. Intraoperative photograph (C) showing the extradural tumor (black arrow) located at the right side of the dural sac (white arrow). A posterior laminectomy approach for tumor removal was then arranged. One main huge tumor was identified around the right L4-5 juxta-facet joint while the other minor was part beneath the spinal lamina. All tumors were excised intraoperatively with preservation of the neural structures. The masses were macroscopically extradural, tophaceous, and soft (Figure 1C). Microscopically, the specimen consisted of countless weakly positive birefringent rhomboid shaped crystals when examined under polarized light (Figure 2A and B). Her symptoms were relieved, and she experienced adequate functional recovery after the operation without recurrence for four years till now.
Figure 2

Histopathological photomicrograph: hematoxylin-eosin stain, magnification ×200 (A) and hematoxylin-eosin stain with polarization gating, magnification ×200 (B) showing numerous pathognomonic positively birefringent rhomboidal crystals (white arrow).

Histopathological photomicrograph: hematoxylin-eosin stain, magnification ×200 (A) and hematoxylin-eosin stain with polarization gating, magnification ×200 (B) showing numerous pathognomonic positively birefringent rhomboidal crystals (white arrow).

Discussion

Patients with CPPD could be characterized by a featured pattern in roentgenography, which exhibits as a high-density linear structure within cartilage known as “chondrocalcinosis”.6,7 Although chondrocalcinosis is usually shown as a characteristic radiological finding, it can also be seen occasionally in ultrasonography.7 Even so, when we find calcification within cartilage, 40% of the patients have concomitant clinically active CPPD disease.8 On the other hand, chondrocalcinosis is not all composite of CPP crystals; some patients present with other non-CPP minerals, such as basic calcium phosphate (BCP).9 BCP crystals encompass three different types of calcium crystals, such as carbonate-substituted hydroxyapatite, octacalcium phosphate, and tricalcium phosphate. Besides, BCP crystals usually produce coin-like calcifications around cartilage. In addition, BCP deposition is too small to be seen in roentgenogram. Finally yet importantly, depositional disease could present as mixed-type deposition from different minerals. It is unusual to find intraspinal cysts in the lumbar spine. Ganglion cysts appeared more likely in the intraspinal extradural space adjacent to the facet joints.10 In our case, the cysts occurred at the level of L4-5 in the spinal canal just about the facet joint, as displayed clearly by MRI and confirmed by a radiologist. Eventually, surgical neural structures decompression in addition to cystic content extirpation demonstrated short diamond crystals that are blue in color under polarized light for the final accurate diagnosis.11 In addition to using microscopes, chest radiographs could also be used to distinguish between gout and CPPD. Konstantinos Parperis pointed out that chondrocalcinosis in the acromioclavicular (AC) joint on chest radiographs is associated with CPPD. Patients with AC joint chondrocalcinosis are more likely to have a history of CPPD crystals than patients without AC joint chondrocalcinosis.12 Christie M. Bartels even proposed the use of A/B/C categories to establish diagnostic criteria for CPPD disease.13 Pseudogout could sometimes mimic spinal tumors or hematomas.14,15 Spinal tumor is generally categorized into three groups; namely extradural tumor, intradural extramedullary tumor, and intradural intramedullary tumor.16 Extradural tumors are located outside the dura, which is the thin covering surrounding the spinal cord. The probability of tumor development in this location is approximately more than half that of the others.17 These are most commonly due to metastatic cancer.16 The representative pattern of malignancy might express multifocal lytic lesions identified by low signals on T1 and high signals on T2 weighted MRI with rim enhancement. Benign tumors should also be considered as a differential diagnosis that includes arachnoid cysts, vertebral hemangioma, or osteoblastoma that may be clinically expressed as local tenderness, limb sensitivity, and motor impairment.16 There are no effective medical measures to prevent CPP crystal accumulation in tissues or to eliminate them because much of the pathogenesis of CPPD deposition remains unclear. Oral colchicine tablets, NSAIDs, and local steroid injections may help control the symptoms. Chollet-Janin and colleagues reported that using 5–10mg of methotrexate (MTX) weekly could improve chronic CPPD.18 Pascual’s laboratory also suggested that MTX might be beneficial for older patients with seronegative symmetrical polyarthritis showing chondrocalcinosis or CPP crystals.19 CPP and uric crystals can activate NLRP3 inflammasome, therefore promoting IL-1β secretion. Hence, IL-1β inhibitors may be used in treating CPP patients. Anakinra is an example of an IL-1β inhibitor, which has a good response in acute gouty attacks and could be chosen to treat CPPD in selected cases.20,21 Another drug known as Tocilizumab is an immunosuppressive remedy that acts on the interleukin-6 receptor (IL-6R) to antagonize humanized monoclonal antibodies. This novel medication is often the recipe for rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis. It appears to be another efficacious and useful option in the treatment of CPPD.22

Conclusion

Spinal extradural tumor with rim enhancement has overlapped arguments as delineated in our report. The radiographical MRI in the current case showed one large cyst and a smaller one behind the other. We present the rare occurrence of pseudogout mimicking lumbar juxta-facet cysts preoperatively. We recommend surgical decompression in symptomatic cases accompanied by nerve root and/or thecal sac compression. This case report raises awareness of CPPD as a cause of axial symptoms. The discovery of chondrocalcinosis should raise the suspicion of pseudogout or secondary osteoarthritis in an appropriate clinical setting. Additionally, in young patients, clinicians should be reminded of the possibility of related metabolic diseases.
  31 in total

Review 1.  Management of calcium pyrophosphate crystal deposition disease: A systematic review.

Authors:  Konstantinos Parperis; Eleni Papachristodoulou; Loukas Kakoullis; Ann K Rosenthal
Journal:  Semin Arthritis Rheum       Date:  2020-12-21       Impact factor: 5.532

Review 2.  Basic calcium phosphate crystal-associated musculoskeletal syndromes: an update.

Authors:  Ann K Rosenthal
Journal:  Curr Opin Rheumatol       Date:  2018-03       Impact factor: 5.006

3.  Lumbar Intradural Ganglion Cyst.

Authors:  Po-An Tai; Tin-Chou Li
Journal:  World Neurosurg       Date:  2015-12-24       Impact factor: 2.104

Review 4.  Current advances in therapies for calcium pyrophosphate crystal arthritis.

Authors:  Francisca Sivera; Mariano Andrés; Eliseo Pascual
Journal:  Curr Opin Rheumatol       Date:  2016-03       Impact factor: 5.006

Review 5.  Calcium pyrophosphate dihydrate crystal deposition disease (pseudogout) of lumbar spine mimicking osteomyelitis-discitis with epidural phlegmon.

Authors:  Mark M Mikhael; Michael A Chioffe; Gary S Shapiro
Journal:  Am J Orthop (Belle Mead NJ)       Date:  2013-08

Review 6.  Intradural calcium pyrophosphate dihydrate deposition disease: case report.

Authors:  Ananya Chakravorty; Ronald T Murambi; Ravi Kumar V Cherukuri
Journal:  J Neurosurg Spine       Date:  2021-03-05

7.  Calcification of articular cartilage in human osteoarthritis.

Authors:  M Fuerst; J Bertrand; L Lammers; R Dreier; F Echtermeyer; Y Nitschke; F Rutsch; F K W Schäfer; O Niggemeyer; J Steinhagen; C H Lohmann; T Pap; W Rüther
Journal:  Arthritis Rheum       Date:  2009-09

Review 8.  Calcium pyrophosphate arthropathy of the spine: case report and review of the literature.

Authors:  M Salcman; A Khan; D A Symonds
Journal:  Neurosurgery       Date:  1994-05       Impact factor: 4.654

9.  Methotrexate: should it still be considered for chronic calcium pyrophosphate crystal disease?

Authors:  Eliseo Pascual; Mariano Andrés; Francisca Sivera
Journal:  Arthritis Res Ther       Date:  2015-04-01       Impact factor: 5.156

Review 10.  Calcium pyrophosphate crystal deposition disease: diagnosis and treatment.

Authors:  José Luis Rosales-Alexander; Jerónimo Balsalobre Aznar; César Magro-Checa
Journal:  Open Access Rheumatol       Date:  2014-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.